These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20153309)

  • 1. Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure.
    Christenson RH; Duh SH; Wu AH; Smith A; Abel G; deFilippi CR; Wang S; Adourian A; Adiletto C; Gardiner P
    Clin Biochem; 2010 May; 43(7-8):683-90. PubMed ID: 20153309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance characteristics of the ARCHITECT Galectin-3 assay.
    La'ulu SL; Apple FS; Murakami MM; Ler R; Roberts WL; Straseski JA
    Clin Biochem; 2013 Jan; 46(1-2):119-22. PubMed ID: 23010446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.
    Lee-Lewandrowski E; Januzzi JL; Green SM; Tannous B; Wu AH; Smith A; Wong A; Murakami MM; Kaczmarek J; Apple FS; Miller WL; Hartman K; Jaffe AS
    Clin Chim Acta; 2007; 386(1-2):20-4. PubMed ID: 17854790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-linked immunosorbent assay of total inhibin: direct determination based on inhibin alpha subunit-specific monoclonal antibodies.
    Khosravi J; Krishna RG; Khaja N; Bodani U; Diamandi A
    Clin Biochem; 2004 May; 37(5):370-6. PubMed ID: 15087252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.
    Saussez S; Lorfevre F; Lequeux T; Laurent G; Chantrain G; Vertongen F; Toubeau G; Decaestecker C; Kiss R
    Oral Oncol; 2008 Jan; 44(1):86-93. PubMed ID: 17350328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices.
    Milting H; Ellinghaus P; Seewald M; Cakar H; Bohms B; Kassner A; Körfer R; Klein M; Krahn T; Kruska L; El Banayosy A; Kramer F
    J Heart Lung Transplant; 2008 Jun; 27(6):589-96. PubMed ID: 18503956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin 3 and its binding protein in rheumatoid arthritis.
    Ohshima S; Kuchen S; Seemayer CA; Kyburz D; Hirt A; Klinzing S; Michel BA; Gay RE; Liu FT; Gay S; Neidhart M
    Arthritis Rheum; 2003 Oct; 48(10):2788-95. PubMed ID: 14558084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical evaluation of the automated galectin-3 assay on the Abbott ARCHITECT immunoassay instruments.
    Gaze DC; Prante C; Dreier J; Knabbe C; Collet C; Launay JM; Franekova J; Jabor A; Lennartz L; Shih J; del Rey JM; Zaninotto M; Plebani M; Collinson PO
    Clin Chem Lab Med; 2014 Jun; 52(6):919-26. PubMed ID: 24445238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients.
    Lin YH; Lin LY; Wu YW; Chien KL; Lee CM; Hsu RB; Chao CL; Wang SS; Hsein YC; Liao LC; Ho YL; Chen MF
    Clin Chim Acta; 2009 Nov; 409(1-2):96-9. PubMed ID: 19747906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3: a novel mediator of heart failure development and progression.
    de Boer RA; Voors AA; Muntendam P; van Gilst WH; van Veldhuisen DJ
    Eur J Heart Fail; 2009 Sep; 11(9):811-7. PubMed ID: 19648160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance characteristics of the Access Inhibin A assay.
    Rawlins ML; La'ulu SL; Erickson JA; Roberts WL
    Clin Chim Acta; 2008 Nov; 397(1-2):32-5. PubMed ID: 18691567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.
    Latini R; Masson S; Anand IS; Missov E; Carlson M; Vago T; Angelici L; Barlera S; Parrinello G; Maggioni AP; Tognoni G; Cohn JN;
    Circulation; 2007 Sep; 116(11):1242-9. PubMed ID: 17698733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
    Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodological and preanalytical evaluation of an HMGB1 immunoassay.
    Lehner J; Wittwer C; Fersching D; Siegele B; Holdenrieder S; Stoetzer OJ
    Anticancer Res; 2012 May; 32(5):2059-62. PubMed ID: 22593488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole blood interleukin-8 concentrations in capillary and cord blood of neonates for the diagnosis of systemic inflammatory states.
    Kohse KP; Carl A; Steinbach G
    Clin Lab; 2002; 48(9-10):497-503. PubMed ID: 12389710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological and preanalytical evaluation of a RAGE immunoassay.
    Wittwer C; Lehner J; Fersching D; Siegele B; Stoetzer OJ; Holdenrieder S
    Anticancer Res; 2012 May; 32(5):2075-8. PubMed ID: 22593491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females.
    Al-Qahtani A; Muttukrishna S; Appasamy M; Johns J; Cranfield M; Visser JA; Themmen AP; Groome NP
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):267-73. PubMed ID: 16117813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.